Onco-Innovations Limited
ONCO
| 10/31/2025 | 07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 110.60K | 60.20K | 46.00K | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 110.60K | 60.20K | 46.00K | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 110.60K | 60.20K | 46.00K | -- | -- |
| SG&A Expenses | 4.23M | 2.33M | 2.02M | -- | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.90M | 2.68M | 2.19M | -- | -- |
| Operating Income | -4.79M | -2.62M | -2.15M | -- | -- |
| Income Before Tax | -10.16M | -7.69M | -5.99M | -- | -- |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -10.16 | -7.69 | -5.99 | -- | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -10.16M | -7.69M | -5.99M | -- | -- |
| EBIT | -4.79M | -2.62M | -2.15M | -- | -- |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.25 | -0.21 | -0.18 | -- | -- |
| Normalized Basic EPS | -0.11 | -0.08 | -0.06 | -- | -- |
| EPS Diluted | -0.25 | -0.21 | -0.18 | -- | -- |
| Normalized Diluted EPS | -0.11 | -0.08 | -0.06 | -- | -- |
| Average Basic Shares Outstanding | 174.65M | 158.70M | 139.80M | -- | -- |
| Average Diluted Shares Outstanding | 174.65M | 158.70M | 139.80M | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |